Research

Hormonal

The development of oral formulations such as oral Semaglutide is expected to provide convenience for patients and enhance their willingness to receive treatment.

Practitioners should consider the potential of oral Semaglutide to improve patient adherence to obesity treatment.

StrongSupportsmedium confidence
Furthermore, the development of oral formulations such as oral Semaglutide is expected to provide convenience for patients and enhance their willingness to receive treatment.
Xingrong Feng et al. · Chinese Medical Journal · 2025

Why this rating

The claim is based on a review of treatment innovations.

Source

Obesity and emerging intervention strategies: Mechanistic insights and novel drug targets

Xingrong Feng et al. · Chinese Medical Journal · 2025

DOI 10.1097/cm9.0000000000003919

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →